ARISING HEALTHALIVE. AWAKE. AWARE.Read the magazines →

← All editions

THE ARISING · EDITED READER EDITION

The Arising · November 15 Edited Reader Edition

This edited reader edition includes 6 reviewed articles from November 15, 2026. It is not the complete original issue. It includes 6 of the original 46 stories; 40 are not included here.

Longevity & Healthspan

How aerobic capacity differed by age in women who compete in endurance sports

A review of 69 studies offers reference values for women Masters athletes. It does not tell an individual how quickly her fitness will change.

Women competing in endurance sports at older ages had lower measured aerobic capacity on average than their younger counterparts, according to a systematic review published in Sports Medicine. The authors estimated an age difference of about 12% per decade. That figure compares groups at different ages. It is not a forecast for any individual athlete.

The review combined studies of 1,903 female Masters athletes aged 40 and older. Researchers looked at VO₂ max, the maximum rate at which the body uses oxygen during intense exercise. In this review it was reported relative to body mass, in milliliters of oxygen per kilogram per minute. The pooled average was 45 for athletes in their 40s, 40 in their 50s, 35 in their 60s and 30 among those aged 70 and older.

Fitting a model across the pooled data gave a difference of 0.57 units per additional year of age, which the authors summarized as approximately 11.7% per decade. That is a modeled average from age-group comparisons. The studies do not show that a particular athlete loses exactly that share every ten years. They also don't tell us how much of the difference comes from aging itself, differences in training histories, or which athletes continue to compete at older ages.

The research fills a gap: much of the work on age and aerobic capacity in Masters athletes has focused on men. These data offer a better comparison for women in endurance sport. They don't establish that training stops or fails to slow a decline; this analysis cannot answer what the same women would have experienced with different training.

The next step is to test the same athletes repeatedly over years. That would clarify how aerobic capacity changes within a person and how those changes relate to training and performance.

Primary source: *Sports Medicine*, November 12, 2026

Open this article on its own →

Longevity & Healthspan

An experimental antibody reduced lean-mass loss in a semaglutide trial

A randomized phase 2 trial found a difference on body-composition scans. It did not establish that participants became stronger or moved better.

When someone loses weight, the number on the scale doesn't show how much came from fat and how much came from lean tissue. The COURAGE trial, published in The Lancet, asked whether adding trevogrumab, an experimental antibody that blocks the muscle-growth regulator myostatin, could reduce lean-mass loss in adults with obesity taking semaglutide.

The two-part trial enrolled 975 adults. In the 26-week part, lean mass fell by 6.6% on average in the semaglutide-plus-placebo group. Adding trevogrumab reduced that loss by an estimated 3.1 percentage points in one dose group (95% confidence interval 1.9 to 4.3) and 2.7 points in the other (1.5 to 4.0). Both doses should be regarded as trial comparisons, not treatment or dosing recommendations. A separate 52-week part used different doses: its higher dose reduced lean-mass loss relative to placebo, while the confidence interval for the lower dose included no difference.

A separate group also received a second experimental antibody, garetosmab. That combination preserved more lean mass at 26 weeks but had a worse safety and tolerability profile. Fourteen of 149 people had serious adverse events and 48 discontinued treatment. Two participants in that group died; the investigators did not identify a causal link to treatment. The combination's results should not be conflated with those for trevogrumab alone.

The trial was funded by Regeneron, trevogrumab's developer. Its central finding is about measured body composition. Lean mass and muscle strength are not interchangeable: retaining more lean tissue on a scan doesn't tell us whether participants found it easier to climb stairs, carry groceries or maintain independence. Those are outcomes a later trial would have to measure directly.

This phase 2 result is not a reason to change a prescription or seek the experimental combination.

Primary source: COURAGE trial, *The Lancet*, November 11, 2026

Open this article on its own →

Longevity & Healthspan

Exercise and bone density after menopause: the results differed by site

A review found gains on bone density scans in women with low bone density. It did not show that one type of exercise prevents more fractures than another.

When an exercise trial reports better bone density, the result may depend on which part of the skeleton the researchers measured. A review in Frontiers in Public Health combined 30 randomized trials involving 2,149 postmenopausal women with osteopenia or osteoporosis. It compared aerobic exercise, resistance exercise and programs combining the two.

At the lower spine, all three types improved bone mineral density relative to their control groups. The estimate for aerobic exercise was 0.042 grams per square centimeter higher than control. At the femoral neck, the narrow part of the thigh bone near the hip, both aerobic and resistance exercise showed gains in the pooled results.

The total hip was different. Across eight trials with 677 participants, resistance exercise was the only category with a statistically clear gain relative to control. The estimate was 0.062 grams per square centimeter (95% confidence interval 0.029 to 0.096). The results for aerobic and combined programs were uncertain at that site, not proof that they have no effect.

The analysis brings together both direct comparisons and comparisons made through a shared control. Those controls were not identical across trials, and a category's ranking is not proof it would beat the others head to head. The authors found only one trial at low risk of bias. The findings describe changes on bone density scans, not how many people avoided a hip or spine fracture.

The useful takeaway is narrower than “one best exercise.” Exercise trials can produce different findings at different bones, and the evidence is strongest when the comparison matches both the exercise and the outcome you care about. Anyone already receiving care for osteoporosis or a fragility fracture should use these results as a conversation starter, not as a substitute for an individualized plan.

Primary source: *Frontiers in Public Health*, November 12, 2026

Open this article on its own →

Longevity & Healthspan

Physical activity and coronary heart disease: the association differed by age

A large study used wrist-worn movement sensors. It found a stronger association in adults 65 and older, but it did not establish how much exercise any one person needs.

Researchers analyzed movement data from 80,243 UK Biobank participants. About 31,700 were 65 or older. They compared how much moderate-to-vigorous activity participants recorded with their likelihood of developing coronary heart disease during follow-up. Coronary heart disease affects the arteries supplying the heart; the study did not measure every kind of heart disease.

Meeting the study's activity benchmark was associated with a lower rate of coronary heart disease in both age groups. The association was stronger in the older group: its adjusted hazard ratio was 0.72, versus 0.85 in the group under 65. A hazard ratio below 1 indicates a lower rate over follow-up relative to the study comparison group. It does not tell a person their chances of having an event.

The researchers also modeled how the association changed across different amounts of activity. In that model, a similar relative difference appeared at fewer weekly minutes in the older group. That is not a minimum effective dose. The researchers did not randomly assign people to exercise schedules. Differences in health, mobility and daily routines could affect both how much people moved and their likelihood of developing disease. A wrist sensor records movement, but the same signal doesn't necessarily represent the same effort for everyone.

The study gives researchers a reason to examine how age affects the link between activity and coronary health. It doesn't support a new exercise target for adults over 65 or a conclusion that younger people must exercise more.

Primary source: *Journal of the American Heart Association*

Open this article on its own →

Nutrition

A small IBS trial tested adding resistant starch to a low-FODMAP diet

Average symptoms were stable over three weeks among people who completed the trial. That doesn't establish that the blend improves IBS symptoms or is tolerable for everyone.

A low-FODMAP diet limits certain fermentable carbohydrates to help manage symptoms of irritable bowel syndrome, or IBS. A small Australian trial asked whether adults with stable IBS who were already following that diet could add a blend of resistant starch and psyllium without worsening their symptoms. The study appeared in the European Journal of Nutrition in September and is revisited here.

The double-blind pilot lasted three weeks after a baseline week. Twenty-six people completed it, 13 in each group. One group received the blend; the comparison group received maize flour without resistant starch and the same amount of psyllium. The study therefore did not test whether psyllium alone helps IBS.

Among people included in the analysis, the groups' symptom scores and sleep patterns stayed roughly stable. The researchers found differences in which bacteria were present at the end of the trial, but the overall analysis did not establish that bacterial composition changed differently over time between groups. The researchers also reported a signal of reduced gut-specific anxiety. Neither result demonstrates lasting symptom relief. One participant who received the blend stopped taking it after reporting nausea; that participant was not included in the analysis.

The short duration, small sample and exclusions matter. The paper also identifies a patent application for the formulation. This was a feasibility signal in a selected group, not a reason to buy the product, try the trial regimen, or change an IBS diet without guidance.

Primary source: *European Journal of Nutrition*, September 24, 2026

Open this article on its own →

Connection

Loneliness and social isolation each tracked with later health

An 18-country study found that feeling disconnected and having fewer social ties were each associated with poorer health after age 50. It did not test a remedy.

Someone can spend a great deal of time alone and feel connected to the people who matter to them. Someone else can have frequent company and still feel lonely. An international study in BMC Medicine measured those experiences separately and looked at how each related to health.

Researchers combined data from five studies of aging, spanning 94,122 adults aged 50 or older in 18 countries. Follow-up ranged from two to ten years. The study used survey measures of social contact and participation for isolation, and questions about how connected people felt for loneliness. It examined reports of physical and mental health conditions as well as how participants rated their own health.

Both experiences were associated with poorer health at later assessments. The clearest differences for loneliness were in mental health and self-rated health. People who reported both experiences, or reported them at multiple early assessments, tended to have worse later outcomes than people with neither. These are group-level patterns, not forecasts for any individual.

Following people over time helps establish the order in which answers were recorded. It doesn't settle cause and effect. Poor health can make it harder to stay socially engaged, and other circumstances can shape both connection and health. Survey responses and cohort differences also limit how directly results can be compared from one country to another.

The findings support asking two different questions: how often a person has meaningful contact, and whether they feel connected. They don't show that increasing contact alone will make a person less lonely or improve their health.

Primary source: *BMC Medicine*, November 10, 2026

Open this article on its own →

THE ARISING NEWSLETTER

Science moves forward.
Come with it.

Research, clear explanations, and a little room for wonder.
Read and follow The Arising on Substack.

Find The Arising on Substack ↗